OccamzRazor

Private

New York City, New YorkHealthcare & Life Scienceshttps://www.occamzrazor.com/

Last Round

Series A

Mar 8, 2022

Total Funding Raised

$12M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

OccamzRazor is a digital biotechnology company that uses artificial intelligence and machine learning to discover and develop treatments for complex diseases of brain aging, with a focus on Parkinson's disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

AI drug discoveryAI biotechneurodegenerative diseasetechbioParkinson's diseasetherapeutic target identificationAI-generated therapiesdrug discovery platformbiomedical knowledge graphgraph machine learningin silico drug discoveryclinical-stage biotechpreclinical developmentnatural language processingNLP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OccamzRazor Comparables

Compare OccamzRazor with similar companies based on industry and business-model similarity.

OccamzRazor comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

OccamzRazor Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Mar 8, 2022
Seed	Oct 1, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Robbie Narang

Chief Executive Officer

Executive Team

OccamzRazor Investors

Notable investors and investment history

OccamzRazor investors
Investor	Rounds
re.Mind Capital	Series A
Bioverge	Seed, Series A
Techammer	Seed
Valor Equity Partners	Series A
Lanx Capital	Seed
Lauder Partners	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 24, 2026
Monthly visitors grew 212% MoM, reaching 799.
Apr 21, 2026
Monthly visitors increased 771% MoM, from 66 to 575.

View all signals

OccamzRazor Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

OccamzRazor Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OccamzRazor's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York

Employee Range7

Year Founded2015

Last FundingMar 8, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.